Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,515 | 197 | 98.7% |
| Education | $59.98 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,892 | 85 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $567.58 | 10 | $0 (2024) |
| Allergan, Inc. | $453.23 | 35 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $393.27 | 15 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $251.73 | 6 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $191.61 | 8 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $181.52 | 10 | $0 (2017) |
| Alkermes, Inc. | $167.99 | 3 | $0 (2023) |
| ITI, Inc. | $149.75 | 7 | $0 (2023) |
| Lundbeck LLC | $73.90 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $519.09 | 21 | ABBVIE INC. ($295.73) |
| 2023 | $1,337 | 54 | ABBVIE INC. ($1,076) |
| 2022 | $224.23 | 6 | Teva Pharmaceuticals USA, Inc. ($139.89) |
| 2021 | $797.45 | 41 | AbbVie Inc. ($472.18) |
| 2020 | $365.44 | 26 | Allergan, Inc. ($134.68) |
| 2019 | $232.03 | 2 | Alkermes, Inc. ($124.64) |
| 2018 | $384.86 | 11 | Sunovion Pharmaceuticals Inc. ($122.65) |
| 2017 | $714.62 | 38 | Allergan Inc. ($255.19) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.26 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $106.14 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/21/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/20/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: BH | ||||||
| 02/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 122 | 293 | $39,173 | $13,174 |
| 2022 | 6 | 244 | 606 | $75,990 | $30,792 |
| 2021 | 7 | 341 | 841 | $87,540 | $41,303 |
| 2020 | 10 | 368 | 642 | $72,268 | $31,292 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 39 | 86 | $19,350 | $6,181 | 31.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 50 | $8,250 | $3,095 | 37.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 30 | $6,000 | $1,978 | 33.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 41 | 116 | $2,900 | $1,089 | 37.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $2,673 | $830.25 | 31.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 64 | 172 | $29,965 | $14,126 | 47.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 160 | $26,498 | $8,925 | 33.7% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 63 | 175 | $5,057 | $3,255 | 64.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 19 | 20 | $9,064 | $2,266 | 25.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 18 | 18 | $4,404 | $1,538 | 34.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 45 | 61 | $1,003 | $681.56 | 68.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 68 | 173 | $25,955 | $16,194 | 62.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 150 | $25,800 | $8,690 | 33.7% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 81 | 248 | $7,440 | $4,393 | 59.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 41 | 74 | $7,400 | $4,372 | 59.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 22 | 25 | $9,125 | $3,514 | 38.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 26 | 30 | $7,590 | $2,574 | 33.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 74 | 141 | $4,230 | $1,567 | 37.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 131 | $22,532 | $7,912 | 35.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 72 | 126 | $12,600 | $7,312 | 58.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 34 | 48 | $7,200 | $4,061 | 56.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 52 | $7,800 | $3,268 | 41.9% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 81 | 151 | $4,530 | $3,054 | 67.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 17 | 20 | $7,300 | $2,339 | 32.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 17 | 22 | $5,566 | $1,877 | 33.7% |
About Dr. Maria Gonzalez, MD
Dr. Maria Gonzalez, MD is a Psychiatry healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114982857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maria Gonzalez, MD has received a total of $4,575 in payments from pharmaceutical and medical device companies, with $519.09 received in 2024. These payments were reported across 199 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,515).
As a Medicare-enrolled provider, Gonzalez has provided services to 1,075 Medicare beneficiaries, totaling 2,382 services with total Medicare billing of $116,562. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Cranston, RI
- Active Since 04/18/2006
- Last Updated 10/03/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114982857
Products in Payments
- VRAYLAR (Drug) $2,346
- REXULTI (Drug) $596.74
- LATUDA (Drug) $393.27
- AUSTEDO (Drug) $251.73
- SUNOSI (Drug) $191.61
- CAPLYTA (Drug) $149.75
- ARISTADA (Drug) $145.72
- BELSOMRA (Drug) $134.77
- Auvelity (Drug) $57.98
- TRINTELLIX (Drug) $51.04
- NUEDEXTA (Drug) $36.62
- Azstarys (Drug) $33.41
- LYBALVI (Drug) $22.27
- SPRAVATO (Drug) $22.26
- BRINTELLIX (Drug) $19.25
- INGREZZA (Drug) $18.26
- Dayvigo (Drug) $18.08
- APLENZIN (Drug) $14.84
- PERSERIS (Drug) $13.59
- INVEGA SUSTENNA (Drug) $11.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Cranston
Dr. Richard Miller, M.d, M.D
Psychiatry — Payments: $764,696
Mark Zimmerman, Md, MD
Psychiatry — Payments: $218,647
Dr. Gene Jacobs, D.o, D.O
Psychiatry — Payments: $29,145
Robert Bessette, D.o, D.O
Psychiatry — Payments: $13,613
Dr. John Ruggiano, M.d, M.D
Psychiatry — Payments: $10,571
Dr. Bruce Fischer, Md, MD
Psychiatry — Payments: $193.28